Clinical trial · Interventional
Exploring Participant Preference for Screening Methods and Experience Into Colorectal Cancer Screening Programme
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this low-risk interventional study is to analyze participants' assessment of colorectal cancer screening program through screening method preference and experience after FOBT analysis in screaned participant population for colorectal cancer; could include any of the following: both sexes, age 50-69 years, asympthomatic volunteers. The main aims to answer are: * Values of experience of participants into screening programme. * Values of preferences of participants for screening methods. Participants will answer two questionnaires and they'll be given their information and clinical data to investigator or health personnel.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Screening for Colon Cancer | Colorectal Neoplasm | PROBABILISTIC | 0.70 |
| Survey and Questionnaire | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Survey using a questionnaire. | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- FIT/FOBT population
- description
- Average-risk population undergoing FIT/FOBT within the colorectal cancer screening programme.
- interventionNames
- Other: Survey using a questionnaire.
Primary outcomes (1)
- measure
- Value of questionnaires into screening programme
- timeFrame
- 12 months
- description
- The percentage of number of answers from each experience and preference questions
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 50 Years
- Maximum age
- 69 Years
Show eligibility criteria text
Inclusion Criteria: * Participants ages from 50 to 69 years (both included) at the time of informed consent signed. * Participants invited to participate in population-based screening programme who are eligible to undertake FOBT at the Primary Health Care Center. * Participants should sign an informed consent. They must understand the nature, significance, implications, and risks of the clinical study before signing the informed consent form. Exclusion Criteria: * Participants who have not delivery a stool sample in the Primary Health Care Center before signing the informed consent form. * Participants with a previous colonoscopy in consequence of a FOBT positive result. * Participants who are in a dependent personal or non-medical relationship with the Sponsor or the Investigators.
References
Publications (3)
- RESULTAdler A, Geiger S, Keil A, Bias H, Schatz P, deVos T, Dhein J, Zimmermann M, Tauber R, Wiedenmann B. Improving compliance to colorectal cancer screening using blood and stool based tests in patients refusing screening colonoscopy in Germany. BMC Gastroenterol. 2014 Oct 17;14:183. doi: 10.1186/1471-230X-14-183. PMID 25326034
- RESULTDe Angelis R, Demuru E, Baili P, Troussard X, Katalinic A, Chirlaque Lopez MD, Innos K, Santaquilani M, Blum M, Ventura L, Paapsi K, Galasso R, Guevara M, Randi G, Bettio M, Botta L, Guzzinati S, Dal Maso L, Rossi S; EUROCARE-6 Working Group. Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study. Lancet Oncol. 2024 Mar;25(3):293-307. doi: 10.1016/S1470-2045(23)00646-0. Epub 2024 Jan 30. PMID 38307102
- RESULTSiegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023 May-Jun;73(3):233-254. doi: 10.3322/caac.21772. Epub 2023 Mar 1. PMID 36856579